Global WholeHealth Partners Corporation

Equities

GWHP

US37959N1028

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 20:02:43 10/05/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	-99.00%

2022	Global WholeHealth Partners Corporation Reports Earnings Results for the Full Year Ended June 30, 2022	CI
2022	Global WholeHealth Partners Corporation Auditor Raises 'Going Concern' Doubt	CI

Global WholeHealth Partners Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021

February 03, 2022 at 10:27 pm

Global WholeHealth Partners Corporation reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported net loss was USD 2.62 million compared to USD 0.185654 million a year ago. Basic loss per share from continuing operations was USD 0.03.
For the six months, sales was USD 0.000375 million compared to USD 0.03746 million a year ago. Net loss was USD 4.05 million compared to USD 0.432817 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.01 a year ago.

Latest news about Global WholeHealth Partners Corporation

Global WholeHealth Partners Corporation Reports Earnings Results for the Full Year Ended June 30, 2022	17/10/22	CI
Global WholeHealth Partners Corporation Auditor Raises 'Going Concern' Doubt	16/10/22	CI
Global WholeHealth Partners Corporation Announces Executive Changes	16/08/22	CI
Global WholeHealth Partners Corporation Announces Appointment of F. Rene Alvarez, Jr. as Chief Executive Officer	16/08/22	CI
Global WholeHealth Partners Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	20/07/22	CI
Global Wholehealth Partners Corporation Announces Board and Executive Changes	20/07/22	CI
Global WholeHealth Partners Corporation Accepts Resignation of Charles Strongo as Chief Executive Officer	20/07/22	CI
Global WholeHealth Partners Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	03/02/22	CI
Global WholeHealth Partners Corporation Declares Special Common Stock Dividend, Payable on April 1, 2022	13/01/22	CI
Global WholeHealth Partners Corporation Reports Earnings Results for the First Quarter Ended September 30, 2021	05/11/21	CI
Global WholeHealth Partners Signs a Binding MOU With Pan Probe Biotech and AvantGen to Develop the Newest COVID-19 Antigen Test on the Market	25/10/21	CI
Global WholeHealth Partners Corp Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market	29/09/21	CI
Global Wholehealth Partners Corporation Reports Earnings Results for the Full Year Ended June 30, 2021	27/09/21	CI
Global WholeHealth Partners Corporation Auditor Raises 'Going Concern' Doubt	26/09/21	CI
Global WholeHealth Partners Corp Now Able to Sell Through Shopify’s Multibillion Dollar Online Platform	14/09/21	CI
Global WholeHealth Partners Corp Gains Approval in the Ability to Sell Through Shopify’s Multibillion Dollar Online Platform	07/09/21	CI
FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp	24/08/21	CI
Global Wholehealth Partners Corp. Announces Approval in Deal to Sell Through Ebay's $100 Billion Online Marketplace	10/08/21	CI
Global Wholehealth Partners, Corp. Confirms They Offer Antibody and Antigen Test Kits That Detect Fast Spreading Mutated COVID-19 Strains, DELTA (B.1.617.2), (UK (B.1.1.7), S. Africa (B. 1.351)	13/07/21	CI
Global Wholehealth Partners Corp Ships its First Shipment of over 20,000 Tests to Salud Previa of Tijuana, MX	08/07/21	CI
Global WholeHealth Partners Corp Acquires Rights to Distribute & Sell a 3rd COVID-19 Vaccine - Moderna	29/06/21	CI
Global WholeHealth Partners Corporation acquired distribution and selling rights of Moderna Vaccine of Nunzia Pharmaceutical Corporation.	24/06/21	CI
Global WholeHealth Partners Corp. Acquires Rights to Distribute & Sell a 2nd COVID-19 Vaccine - The Pfizer-BioNTech	21/06/21	CI
Global Wholehealth Partners Corporation Partners with Nunzia Pharmaceutical Inc. to Distribute and Sell the Pfizer-BioNTech COVID-19 Vaccine	16/06/21	CI
Global Wholehealth Partners Corporation Grants the Rights from Nunzia Pharmaceutical Inc. to Distribute and Sell the Johnson & Johnson Covid-19 Vaccine	10/06/21	CI

Chart Global WholeHealth Partners Corporation

Duration

Period

Chart Global WholeHealth Partners Corporation

More charts

Company Profile

Global WholeHealth Partners Corporation develops and markets in-vitro diagnostic tests for over the counter (OTC), or consumer-use and point-of-care (POC), which includes hospitals, physiciansâ offices and medical clinics, including those within penal systems throughout the United States and abroad. The Company markets a range of diagnostic test kits for consumer use through OTC sales, and for use by health care professionals, generally located at medical clinics, physician offices and hospitals known as POC, in the United States. These test kits are known as in-vitro diagnostic test kits or IVD products. The Company has its manufacturing, warehousing and laboratories in San Diego and Escondido, California.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
GLOBAL WHOLEHEALTH PARTNERS CORPORATION	-99.00%	143
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
CENCORA, INC.	+9.36%	44.8B
HOYA CORPORATION	+2.70%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.51%	32.3B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
TERUMO CORPORATION	+13.67%	25.02B

Other Medical Equipment, Supplies & Distribution